Skip to main content
OpenTrials
Completed

NCT Number: NCT04994457

Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care

The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

1 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bascom Palmer Eye Institute

Miami, Florida, 33136, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion:

  • Any individual who is physically able to take a virtual reality visual field test
  • Patients who either have glaucoma, are glaucoma suspects, or have a strong family history of glaucoma, or have other visual field defects, and normal individual
  • Age: Individuals who are old enough to comprehend the instructions and procedures (1-90)

Exclusion:

  • Adults unable to consent, prisoners
  • Participants who are too tired to take a visual field test
  • Participants who refuse to consent
  • Individuals who are functionally unable to use VRVF

Treatment and study plan

Virtual Reality Visual Field

Device

A head-mounted perimeter with a wireless remote connected to a laptop that monitors responses

Standard Automated Perimetry

Diagnostic Test

Standard of care perimeter

Primary outcomes

  1. Sensitivity of VRVF compared to SAP

    Time frame: Day 1

    Sensitivity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP

  2. Specificity of VRVF compared to SAP

    Time frame: Day 1

    Specificity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP

Secondary outcomes

  1. Variability of Mean Deviation

    Time frame: Day 1

    Variability of the mean deviation scores obtained from VRVF and SAP

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Aug 6, 2021
Registry last updated
Jun 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.